Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Functional MRI to Assess Functional Hypothalamic Activation in Response to Diazoxide

NCT03566511 is registered in ClinicalTrials.gov with Meredith Hawkins as lead sponsor.

NCT NCT03566511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03566511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Functional MRI to Assess Functional Hypothalamic Activation in Response to Diazoxide
Lead sponsor
Meredith Hawkins
Phase
Phase 2
Overall status
Terminated
Start date
June 12, 2018
Completion date
August 1, 2020
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, glucose metabolism disorders (including diabetes mellitus), glucose, high blood